ctDNA to detect minimal residual disease in pancreatic cancer: moving into clinical trials

dc.contributor.author Montagut Viladot, Clara
dc.contributor.author Vidal Barrull, Joana
dc.date.accessioned 2019-11-08T08:37:32Z
dc.date.issued 2019
dc.format.mimetype application/pdf
dc.identifier.citation Montagut C, Vidal J. ctDNA to detect minimal residual disease in pancreatic cancer: moving into clinical trials. Ann Oncol. 2019 Sep 1;30(9):1410-1413. DOI 10.1093/annonc/mdz236
dc.identifier.doi http://dx.doi.org/10.1093/annonc/mdz236
dc.identifier.issn 0923-7534
dc.identifier.uri http://hdl.handle.net/10230/42791
dc.language.iso eng
dc.publisher Oxford University Press
dc.rights © Oxford University Press. This is a pre-copyedited, author-produced version of an article accepted for publication in Annals of oncology, following peer review. The version of record Montagut C, Vidal J. ctDNA to detect minimal residual disease in pancreatic cancer: moving into clinical trials. Ann Oncol. 2019 Sep 1;30(9):1410-1413, is available online at: https://academic.oup.com/annonc/article/30/9/1410/5550334. DOI 10.1093/annonc/mdz236
dc.rights.accessRights info:eu-repo/semantics/openAccess
dc.subject.other Pàncrees -- Càncer
dc.title ctDNA to detect minimal residual disease in pancreatic cancer: moving into clinical trials
dc.type info:eu-repo/semantics/article
dc.type.version info:eu-repo/semantics/acceptedVersion

Col·leccions